Publication | Closed Access

Effects of the novel nonsteroidal mineralocorticoid receptor blocker, esaxerenone (CS-3150), on blood pressure and urinary angiotensinogen in low-renin Dahl salt-sensitive hypertensive rats

HypertensionSodium HomeostasisMedicineAntihypertensive TherapyPhysiologyChronic Kidney DiseaseUrinary AngiotensinogenMineralocorticoid Receptor BiologyPharmacologyBlood PressureEndocrine Hypertension